Statistics of malignant tumors of urinary and male urogenital organs in Russia and the countries of the former USSR

The study objective is to analyze incidence of cancer morbidity and morality in Russia and some former Soviet states. Prevalence of urinary and male urogenital organs cancer continues to grow. Morphological verification of the diagnosis varied from 58.5 % (at bladder cancer in Tajikistan) up to 93.7 % (in Russia), at a prostate cancer the maximum values are registered in Russia, Belarus and Ukraine (91–99 %); at kidney cancer in Russia, Belarus and Uzbekistan (84 %). In 2012–2017 years the increase of kidney cancer incidence in Russia (in men) made 13.8 %; at a prostate cancer, growth of the standardized rates is registered in all provided countries of the former USSR (except Kyrgyzstan). Decrease in incidence rates of bladder cancer is registered at men in Belarus, Moldova, Kazakhstan, Armenia and Kyrgyzstan. In Russia and Belarus mortality rates of kidney and a bladder cancer decreased; at a prostate mortality rate for the 5 anniversary is stable in Belarus; its insignificant increase was in Russia (for 3.4 %). The increase of penis cancer incidence in Russia was 24 %. The ratio of the maximum and minimum incidence rates among regions of Russia reached 16-fold sizes (at penis cancer) and 6-fold sizes – at testis tumours. Above, than on average in Russia (2.1 per 100 thousand, male population) testis cancer cases in Belarus (3.0 per 100 thousand). In 2012–2017 the increase of testis cancer incidence in Russia was 16.7 %.